- Founded
- 2018
- Employees
- 30
- Total Funding
- $292M
Founded by Greg Hurlbut, Mark Munson in 2018.
About Sionna Therapeutics
Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current tr
Leadership at Sionna Therapeutics
The team at the top of the org chart.
Mike Cloonan
President & CEO
50 reports
Mark Munson
Co-Founder & VP, Medicinal Chemistry
1 report
Elena Ridloff
CFO & Head of Corporate Development
5 reports
Charlotte McKee
Chief Medical Officer
11 reports
Vanya Sagar
Chief People Officer
2 reports
Andy Chu
Vice President Information Technology
3 reports
Mark M.
Co-founder And Vice President Of Medicinal Chemistry At Sionna Therapeutics
Greg Hurlbut
Co-founder and SVP Head of Research
8 reports
Jen Fitzpatrick
Chief Legal Officer
2 reports
Board
Josh Resnick
Director
Bruce Booth
Board Director
Lucian Iancovici
Director
Peter Thompson
Director
Paul Clancy
Chair
Taiyin Yang
Scientific Advisor